Jinling Pharmaceutical Co Ltd (000919) — Cash Flow Quality Index
Jinling Pharmaceutical Co Ltd (000919) has a Cash Flow Quality Index of 3.68x as of September 2025. Operating cash flow of CN¥74.01 Million exceeds net income of CN¥20.12 Million, indicating high earnings quality where cash backs reported profits. Explore 000919 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jinling Pharmaceutical Co Ltd Cash Flow Quality Index (1999–2024)
Historical Cash Flow Quality Index for Jinling Pharmaceutical Co Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Jinling Pharmaceutical Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Jinling Pharmaceutical Co Ltd (1999–2024)
Year-by-year earnings quality comparison for Jinling Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 000919 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 8.59x | CN¥154.19 Million | CN¥17.95 Million | ▲ +438.5% |
| 2023 | 1.59x | CN¥158.92 Million | CN¥99.65 Million | ▼ -30.3% |
| 2022 | 2.29x | CN¥260.59 Million | CN¥113.87 Million | ▲ +19.9% |
| 2021 | 1.91x | CN¥292.03 Million | CN¥152.94 Million | ▼ -42.6% |
| 2020 | 3.33x | CN¥311.46 Million | CN¥93.66 Million | ▲ +31.1% |
| 2019 | 2.54x | CN¥465.85 Million | CN¥183.68 Million | ▲ +68.9% |
| 2018 | 1.50x | CN¥433.83 Million | CN¥288.88 Million | ▼ -41.4% |
| 2017 | 2.56x | CN¥443.11 Million | CN¥172.93 Million | ▲ +492.5% |
| 2016 | 0.43x | CN¥96.15 Million | CN¥222.33 Million | ▼ -46.7% |
| 2015 | 0.81x | CN¥212.45 Million | CN¥262.00 Million | ▼ -33.7% |
| 2014 | 1.22x | CN¥299.89 Million | CN¥245.16 Million | ▼ -14.3% |
| 2013 | 1.43x | CN¥271.21 Million | CN¥190.06 Million | ▲ +10.2% |
| 2012 | 1.29x | CN¥232.12 Million | CN¥179.26 Million | ▲ +57.8% |
| 2011 | 0.82x | CN¥172.82 Million | CN¥210.62 Million | ▲ +7.4% |
| 2010 | 0.76x | CN¥177.81 Million | CN¥232.70 Million | ▲ +7.1% |
| 2009 | 0.71x | CN¥188.41 Million | CN¥264.01 Million | ▼ -77.9% |
| 2008 | 3.23x | CN¥305.26 Million | CN¥94.37 Million | ▲ +880.0% |
| 2007 | 0.33x | CN¥118.06 Million | CN¥357.67 Million | ▼ -44.4% |
| 2006 | 0.59x | CN¥138.50 Million | CN¥233.47 Million | ▼ -4.7% |
| 2005 | 0.62x | CN¥109.29 Million | CN¥175.52 Million | ▼ -54.9% |
| 2004 | 1.38x | CN¥159.81 Million | CN¥115.83 Million | ▲ +24.7% |
| 2003 | 1.11x | CN¥161.86 Million | CN¥146.23 Million | ▲ +19.3% |
| 2002 | 0.93x | CN¥130.36 Million | CN¥140.52 Million | ▲ +17.2% |
| 2001 | 0.79x | CN¥92.49 Million | CN¥116.81 Million | ▼ -59.2% |
| 2000 | 1.94x | CN¥231.31 Million | CN¥119.24 Million | ▲ +451.0% |
| 1999 | 0.35x | CN¥39.77 Million | CN¥112.96 Million | — |